|
|
||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 271, Issue 5 1231-R1238, Copyright © 1996 by American Physiological Society
ARTICLES |
S. Bovetto, C. Rouillard and D. Richard
Department de Physiologie, Faculte de Medecine, Universite Laval, Quebec, Canada.
Two series of experiments were conducted to investigate the role of corticotropin-releasing hormone (CRH) in the effects of 5-hydroxytryptamine (5-HT) on energy intake and energy expenditure. The first set of experiments was carried out to confirm the influence of 5-HT1A-, 5-HT1B-, 5-HT2A/2C-receptor agonists on the activation of the hypothalamic-pituitary-adrenal axis. Plasma corticosterone levels were measured, and a double-immunolabeling procedure was used to determine whether the neuronal activity marker, c-Fos protein (Fos), could be found within brain neurons containing CRH after treatments with 5-HT1A-, 5-HT1B-, 5-HT2A/2C-receptor agonists. The second series of experiments was conducted to assess the involvement of CRH in the effects of 5-HT on food intake and metabolic rate (VO2). The effects of the 5-HT1A-, 5-HT1B-, 5-HT2A/2C-receptor agonists on food intake and VO2 were measured in rats treated with the CRH antagonist, alpha-helical CRH-(9-41). In both experiments rats were intraperitoneally injected with either a vehicle (NaCl 0.9%), the 5-HT1A-receptor agonist (+/-)-8-hydroxy-2-(di-n-propylamino) tetralin hydrobromide (8-OH-DPAT), the 5-HT1B-receptor agonist 5-methoxy-3-(1,2,3,6-tetrahydro-4-pyridinyl)-1H-indole succinate (RU-24969), or the 5-HT2A/2C-receptor agonist (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane HCl (DOI). Fos immunoreactivity was detectable within the CRH-containing neurons of the paraventricular nucleus of the hypothalamus (PVH) after injection of each of the 5-HT-receptor agonists used. The CRH antagonist alpha-helical CRH-(9-41) attenuated the increases in metabolic rate induced by DOI and 8-OH-DPAT. alpha-Helical CRH did not, however, prevent the effects of RU-24969 and DOI on either nocturnal metabolic rate or food intake. The present results provide further evidence for a role of CRH in 5-HT-mediated thermogenic effect, which likely involves the 5-HT2A/2C receptor during the day and the 5-HT1A receptor during the night. Moreover, these results do not support a role for CRH in 5-HT anorectic effects, which likely involves 5-HT1B and 5-HT2A/2C receptors. Finally, the results of this study indicate that the stimulation of CRH-containing neurons located in the PVH does not necessarily predict changes in food intake and energy expenditure.
This article has been cited by other articles:
![]() |
T. Ishikawa, W. Mizunoya, T. Shibakusa, K. Inoue, and T. Fushiki Transforming growth factor-beta in the brain regulates fat metabolism during endurance exercise Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1151 - E1159. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. E. Levin, D. Richard, C. Michel, and R. Servatius Differential stress responsivity in diet-induced obese and resistant rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1357 - R1364. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Timofeeva, Y. Deshaies, F. Picard, and D. Richard Corticotropin-releasing hormone-binding protein in brain and pituitary of food-deprived obese (fa/fa) Zucker rats Am J Physiol Regulatory Integrative Comp Physiol, December 1, 1999; 277(6): R1749 - R1759. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. I. Rybkin, Y. Zhou, J. Volaufova, G. N. Smagin, D. H. Ryan, and R. B. S. Harris Effect of restraint stress on food intake and body weight is determined by time of day Am J Physiol Regulatory Integrative Comp Physiol, November 1, 1997; 273(5): R1612 - R1622. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |